-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Galectin Therapeutics Inc quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2024.
- Galectin Therapeutics Inc Earnings Per Share, Basic for the quarter ending March 31, 2024 was -0.19 USD/shares, unchanged year-over-year.
- Galectin Therapeutics Inc Earnings Per Share, Basic for the twelve months ending March 31, 2024 was -0.74 USD/shares, a 10.4% decline year-over-year.
- Galectin Therapeutics Inc annual Earnings Per Share, Basic for 2023 was -0.74 USD/shares, a 13.8% decline from 2022.
- Galectin Therapeutics Inc annual Earnings Per Share, Basic for 2022 was -0.65 USD/shares, a 25% decline from 2021.
- Galectin Therapeutics Inc annual Earnings Per Share, Basic for 2021 was -0.52 USD/shares, a 26.8% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)